Mediderm Laboratories is a personal care and pharmaceutical technology company founded to develop applications utilizing a powerful synergistic combination of herbal, cosmeceutical, and medicinal raw materials as topical skin applications for various skin conditions and treatments.
Mediderm Laboratories has built a reputation on the exclusive use of high end and top quality ingredients in its products and pharmaceutical GMP protocols to ensure premium quality, freshness and purity of products.
The enhancement of existing consumer products, as well as the reduction of toxicity in other products through the intensive research and development, allows Mediderm Laboratories to be highly sought-after by many market and industry segments. The company’s technology and products are highly beneficial and of global importance.
Mediderm Laboratories is devoted entirely to the development and marketing of personal care products & pharmaceutical and OTC products as OEM/private label, headed by Dr. Lina Twaian, M.D., the company’s director of research and development. Dr. Twaian’s background has made her uniquely qualified to lead Mediderm into the new century. With degrees in medicine, dermatology, skin biology, cosmetic chemistry and her global experience, has given a unique perspective to Mediderm which currently markets leading personal care (hair care, skin care, body care, self tanners, sunscreens ..) & dermatological and OTC products for the treatment of many skin conditions.
She views the strength of Mediderm as its dedication to being a leading global company in the research, development and marketing of dermatological and personal care enhancement products.
As dermatology, skin treatments and enhancements are going to play an ever-growing role in the 21st Century, people are becoming aware that conditions that effect their skin & hair are treatable and new beauty products are helping them to look and feel better. All of Mediderm’s energy is directed toward ensuring that consumers have the products that they always wanted.